Cargando…

Contact frequency determines outcome of basal insulin initiation trials in type 2 diabetes

AIMS/HYPOTHESIS: The aim of the present study was to investigate whether predetermined contact frequency with the study team and endpoint insulin dose are associated with study outcomes in basal insulin initiation trials in type 2 diabetes. METHODS: A systematic Medline search was performed. Using d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Swinnen, S. G. H. A., DeVries, J. H.
Formato:	Texto
Lenguaje:	English
Publicado:	Springer-Verlag 2009
Materias:	Short Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2759009/ https://www.ncbi.nlm.nih.gov/pubmed/19756479 http://dx.doi.org/10.1007/s00125-009-1527-0

Ejemplares similares

Insulin Therapy for Type 2 Diabetes
por: Swinnen, Sanne G., et al.
Publicado: (2009)

Glycemic control after initiating basal insulin therapy in patients with type 2 diabetes: a primary care database analysis
por: Kostev, Karel, et al.
Publicado: (2015)

Fasting insulin levels correlate with the frequency of hypoglycemic events in people with type 2 diabetes on treatment with sulfonylureas: A pilot study
por: Kolokas, Konstantinos, et al.
Publicado: (2020)

A 24-Week, Randomized, Treat-to-Target Trial Comparing Initiation of Insulin Glargine Once-Daily With Insulin Detemir Twice-Daily in Patients With Type 2 Diabetes Inadequately Controlled on Oral Glucose-Lowering Drugs
por: Swinnen, Sanne G., et al.
Publicado: (2010)

Pharmacokinetic Properties of Liraglutide as Adjunct to Insulin in Subjects with Type 1 Diabetes Mellitus
por: Mader, Julia K., et al.
Publicado: (2016)

Insulin gene VNTR genotype associates with frequency and phenotype of the autoimmune response to proinsulin
por: Durinovic-Belló, I, et al.
Publicado: (2010)

The Distinct Prandial and Basal Pharmacodynamics of IDegAsp Observed in Younger Adults Are Preserved in Elderly Subjects with Type 1 Diabetes
por: Brunner, Martina, et al.
Publicado: (2015)

Comparison of Insulin-Treated Patients with Ambiguous Diabetes Type with Definite Type 1 and Type 2 Diabetes Mellitus Subjects: A Clinical Perspective
por: Laspe, Insa, et al.
Publicado: (2023)

Type 1 diabetes defined by severe insulin deficiency occurs after 30 years of age and is commonly treated as type 2 diabetes
por: Thomas, Nicholas J., et al.
Publicado: (2019)

Persistence with Basal Insulin and Frequency of Hypoglycemia Requiring Hospitalization in Patients with Type 2 Diabetes
por: Roussel, Ronan, et al.
Publicado: (2020)

Milder loss of insulin-containing islets in individuals with type 1 diabetes and type 2 diabetes-associated TCF7L2 genetic variants
por: Redondo, Maria J., et al.
Publicado: (2022)

Utility of an Increment in the Basal Rate during Mealtime in Place of Pre-meal Boluses for Preschool-aged Children with Type 1 Diabetes Using CSII
por: Suzuki, Junichi, et al.
Publicado: (2009)

Initiating Insulin Therapy in Type 2 Diabetic Patients Failing on Oral Hypoglycemic Agents: Basal or prandial insulin? The APOLLO trial and beyond
por: Bretzel, Reinhard G., et al.
Publicado: (2009)

The effectiveness of lixisenatide as an add on therapy to basal insulin in diabetic type 2 patients previously treated with different insulin regimes: a multi-center observational study
por: Božek, Tomislav, et al.
Publicado: (2018)

Basal Insulin Initiation and Maintenance in Adults with Type 2 Diabetes Mellitus in the United States
por: Kalirai, Samaneh, et al.
Publicado: (2020)

Pharmacokinetics of diluted (U20) insulin aspart compared with standard (U100) in children aged 3–6 years with type 1 diabetes during closed-loop insulin delivery: a randomised clinical trial
por: Ruan, Yue, et al.
Publicado: (2014)

The importance of the initial period of basal insulin titration in people with diabetes
por: Khunti, Kamlesh, et al.
Publicado: (2020)

GLP 1 Regulated Intestinal Cell’s Insulin Expression and Selfadaptation before the Onset of Type 2 Diabetes
por: Srivastava, Shivani, et al.
Publicado: (2019)

Exercise habits and glucose management among older adults with type 1 diabetes using insulin pumps
por: Chakrabarti, Anindita, et al.
Publicado: (2022)

Sequential Intensification of Metformin Treatment in Type 2 Diabetes With Liraglutide Followed by Randomized Addition of Basal Insulin Prompted by A1C Targets
por: DeVries, J. Hans, et al.
Publicado: (2012)

Incidence of insulin-requiring diabetes in the US military
por: Gorham, E. D., et al.
Publicado: (2009)

Role of preliminary registry data in development of a clinical trial for an innovative device: a small but integral piece of a health policy initiative
por: Ricci, Donald R., et al.
Publicado: (2017)

The Dermoscopy of Pigmented Basal Cell Carcinoma
por: Kinnera, Boina, et al.
Publicado: (2020)

Serum TRAIL levels increase shortly after insulin therapy and metabolic stabilization in children with type 1 diabetes mellitus
por: Tornese, Gianluca, et al.
Publicado: (2015)

Dulaglutide as an Effective Replacement for Prandial Insulin in Kidney Transplant Recipients with Type 2 Diabetes Mellitus: A Retrospective Review
por: Kim, Hwi Seung, et al.
Publicado: (2021)

Insulin signaling alters antioxidant capacity in the diabetic heart
por: Matsuzaki, Satoshi, et al.
Publicado: (2021)

Initiating insulin therapy in children and adolescents with type 1 diabetes mellitus
por: Wangnoo, Subhash Kumar
Publicado: (2015)

Does Modification to the Approach to Contacting Potential Participants Improve Recruitment to Clinical Trials?
por: Sawhney, Vinit, et al.
Publicado: (2014)

Effects of treadmill running on extracellular basal levels of glutamate and GABA at dentate gyrus of streptozotocin-induced diabetic rats
por: Reisi, Parham, et al.
Publicado: (2010)

A retrospective database analysis of insulin use patterns in insulin-naïve patients with type 2 diabetes initiating basal insulin or mixtures
por: Bonafede, Machaon MK, et al.
Publicado: (2010)

Diabetes associated with dominant insulin gene mutations: outcome of 24-month, sensor-augmented insulin pump treatment
por: Ortolani, Federica, et al.
Publicado: (2015)

Twelve week liraglutide or sitagliptin does not affect hepatic fat in type 2 diabetes: a randomised placebo-controlled trial
por: Smits, Mark M., et al.
Publicado: (2016)

Impact of empagliflozin added on to basal insulin in type 2 diabetes inadequately controlled on basal insulin: a 78‐week randomized, double‐blind, placebo‐controlled trial
por: Rosenstock, J., et al.
Publicado: (2015)

Testosterone supplementation improves glucose homeostasis despite increasing hepatic insulin resistance in male mouse model of type 2 diabetes mellitus
por: Pal, M, et al.
Publicado: (2016)

Association of Peripheral Insulin Resistance and Other Markers of Type 2 Diabetes Mellitus with Brain Amyloid Deposition in Healthy Individuals at Risk of Dementia
por: Pekkala, Timo, et al.
Publicado: (2020)

Successful transfer to sulfonylureas in KCNJ11 neonatal diabetes is determined by the mutation and duration of diabetes
por: Babiker, Tarig, et al.
Publicado: (2016)

Glycaemic control and hypoglycaemia burden in patients with type 2 diabetes initiating basal insulin in Europe and the USA
por: Mauricio, Dídac, et al.
Publicado: (2017)

A practical approach to the clinical challenges in initiation of basal insulin therapy in people with type 2 diabetes
por: Forst, Thomas, et al.
Publicado: (2020)

Basal insulin peglispro versus insulin glargine in insulin‐naïve type 2 diabetes: IMAGINE 2 randomized trial
por: Davies, M. J., et al.
Publicado: (2016)

Insulin Degludec in Type 1 Diabetes: A randomized controlled trial of a new-generation ultra-long-acting insulin compared with insulin glargine
por: Birkeland, Kåre I., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_6l7l5sb6lv9b3io69tv117j06q